The Drug Delivery to the Lungs conference (DDL) is Europe’s premier conference and industry exhibition which is dedicated to pulmonary and nasal drug delivery. The focus is on providing a forum to present through podium and poster presentations recent developments in the field of inhalation therapy. The three-day conference consists of a programme of lectures covering five session themes. Each year the DDL Committee invite a long serving respiratory health professional to deliver the commemorative DDL Lecture as a way of recognising their significant scientific accomplishments achieved in respiratory health. The lecture programme also features a slot dedicated to junior researchers; The Pat Burnell Award encourages students to present their work as a podium and poster presentation and from the finalists who present, a winner is awarded £500 and invited to attend the reviewing panel for the same award the following year. In 2017 the DDL Committee introduced an award to recognise specific individuals who are early on in their career in inhalation science who have achieved significant scientific accomplishment or innovation. The winner of the DDL Emerging Scientist Award presents their research as a podium presentation at the conference as well as receiving a £1,000 prize and certificate.
How can we help?
Do you have a question regarding our services?
Sign up to our Newsletter
All the latest industry insights, news and events direct to your mailbox